By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: TerrAscend Announces Results of Annual General Meeting
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Health

TerrAscend Announces Results of Annual General Meeting

GlobeNews Wire
Last updated: 25/06/2025 2:53 AM
GlobeNews Wire
Share
5 Min Read
TerrAscend Announces Results of Annual General Meeting
SHARE
TerrAscend Announces Results of Annual General Meeting

June 24, 2025 16:30 ET  | Source: TerrAscend

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced the results of its annual meeting of shareholders held on June 24, 2025 (the “Meeting“). Common shareholders at the Meeting affirmatively approved the following resolutions:

  • The re-election of Mr. Craig Collard, Ms. Ira Duarte, Mr. Ed Schutter, Ms. Kara DioGuardi and Mr. Jason Wild as directors of the Company for the ensuing year, the voting results of which are as follows;
Director Number of Shares
For Withheld
Craig Collard 154,140,823 (99.53 %) 726,722 (0.47%)
Ira Duarte 154,141,122 (99.53%) 726,723 (0.47%)
Ed Schutter 154,142,148 (99.53%) 725,397 (0.47%)
Kara DioGuardi 151,700,891(97.96%) 3,166,954 (2.04%)
Jason Wild 154,261,935 (99.61%) 605,910 (0.39%)
  • the ratification of the re-appointment of MNP LLP, as the auditor and independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025 and the authorization of the board of directors of the Company to fix their remuneration; and
Number of Shares
For Withheld
193,909,629 (99.39%) 1,193,696 (0.61%)
  • the approval of a resolution to modify the exercise prices of an aggregate of 3,706,250 stock options of the Company held by certain insiders of the Company, subject to the insider meeting a service period requirement, from their current respective exercise prices to the exercise prices set forth in the Company’s Management Information Circular and Proxy Statement dated April 28, 2025.
Number of Shares
For Against
49,849,207 (79.58%) 12,793,583 (20.42%)

About TerrAscend
TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan, Ohio and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium, Gage and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit www.terrascend.com.

Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend’s operations and financial performance.

For more information regarding TerrAscend:
Ziad Ghanem
Chief Executive Officer
IR@terrascend.com
717-343-5386

Investor Relations Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
Valter@KCSA.com
212-896-1254

You Might Also Like

Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting 2024

Cellenkos Inc. and King Faisal Specialist Hospital & Research Centre, Sign Strategic MOU to Advance T Regulatory Cell Therapies for Unmet Diseases

Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant

Brain Cancer Canada Awards $68,000 Research Grant for Clinical Trial of Anti-Cancer Vaccine Targeting DIPG, the Most Aggressive Pediatric Brain Cancer

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

TAGGED:CA88105E1088Other OTC:TSNDFTSX:TSND

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Shuttle Pharmaceuticals Announces Closing of .25 Million Private Placement Priced At-the-Market Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market
Next Article Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Companys Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Companys Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

Zydus Wellness’ Glucon-D’s ‘Energy Ka Gola’ energizes thousands of children across India
Zydus Wellness’ Glucon-D’s ‘Energy Ka Gola’ energizes thousands of children across India
Health 25/06/2025
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company’s multiomics strategy
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company’s multiomics strategy
Health 25/06/2025
Kia President and CEO Ho Sung Song honored at 2025 Autocar Awards
Automobile 25/06/2025
2025 Kia K4 earns 2025 IIHS TOP SAFETY PICK+ award
Automobile 25/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?